Admission to ICUb and/or death | |||||||||
---|---|---|---|---|---|---|---|---|---|
All episodes N = 217 | Severe disease n = 22 | Unadjusted | Multivariable- adjusted | ||||||
N | (% of episodes) | n | (% of subgroup) | OR | (95% CI) | OR | (95% CI) | ||
Gender | |||||||||
Male | 130 | (60) | 13 | (59) | 1.0 | 1.0 | |||
Female | 87 | (40) | 9 | (41) | 1.0 | (0.4–2.5) | 1.3 | (0.4–4.1) | |
Age, years | |||||||||
18–49 | 19 | (8.8) | 2 | (9.1) | 1.0 | 1.0 | |||
50–64 | 31 | (14) | 2 | (9.1) | 0.6 | (0.1–4.6) | 0.3 | (0.03–3.8) | |
65–79 | 83 | (38) | 10 | (45) | 1.2 | (0.2–5.8) | 0.5 | (0.1–4.1) | |
≥ 80 | 84 | (39) | 8 | (36) | 0.9 | (0.2–4.6) | 0.3 | (0.03–3.5) | |
Obesityc | 98 | (45) | 8 | (36) | 0.7 | (0.3-2.0) | 1.1 | (0.3–3.6) | |
Alcohol abuse | 22 | (10) | 6 | (27) | 4.2 | (1.4–12) | 5.5 | (1.1–28) | |
Malignancy | 62 | (29) | 10 | (45) | 2.3 | (0.9–5.6) | 4.2 | (1.3–13) | |
Cardiovascular diseases | 97 | (45) | 14 | (64) | 2.4 | (0.9–5.9) | 1.4 | (0.2–12) | |
Coronary artery disease | 53 | (24) | 9 | (41) | 2.4 | (1.0-5.9) | 1.7 | (0.4–7.4) | |
Chronic heart failure | 74 | (34) | 11 | (50) | 2.1 | (0.9–5.1) | 2.2 | (0.3–15) | |
Diabetes | 81 | (37) | 10 | (45) | 1.5 | (0.6–3.5) | 1.5 | (0.5–4.7) | |
Rheumatic disease | 14 | (6.5) | 2 | (9.1) | 1.5 | (0.3–7.3) | 2.5 | (0.3–22) | |
Chronic lung disease | 37 | (17) | 6 | (27) | 2.0 | (0.7–5.5) | 1.6 | (0.1-4) | |
Asthma | 20 | (9.2) | 2 | (9.1) | 1.0 | (0.2–4.6) | 0.5 | (0.02-13) | |
COPD | 14 | (6.5) | 4 | (18) | 4.1 | (1.2–14) | 2.5 | (0.1–57) | |
Chronic kidney disease | 30 | (14) | 1 | (4.5) | 0.3 | (0.04–2.1) | 0.2 | (0.02–1.6) | |
Chronic liver disease | 10 | (4.6) | 2 | (9.1) | 2.3 | (0.5–12) | 0.7 | (0.1–8.5) | |
Neurological disease | 44 | (20) | 4 | (18) | 0.9 | (0.3–2.7) | 1.2 | (0.3-5.0) | |
Immunosuppressive treatmentd | 28 | (13) | 2 | (9.1) | 0.7 | (0.1–2.9) | 0.4 | (0.1–3.1) |